4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-055182
President & CEO gave up 852 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
KAKKIS EMIL D · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-14 | Shares withheld for taxes : show line 1 in the form | −852 | $92.69 | $78,972 | 610,189 | D |
Loading xslF345X03/doc4.xml…